Comparative efficacy and safety of warfarin and direct oral anticoagulants in patients with end-stage kidney disease and atrial fibrillation

Article information

Korean J Intern Med. 2026;41(5):965-965

Publication date (electronic) : 2026 September 1

doi : https://doi.org/10.3904/kjim.2025.052.e1

Yujin Yang ¹, Sun Hwa Lee ², Wonmook Hwang ³, Ji Hoon Jung ⁴, Jae-Hyeong Park ¹

¹Department of Cardiology in Internal Medicine, Chungnam National University Hospital, Chungnam National University College of Medicine, Daejeon, Korea

²Division of Cardiology, Department of Internal Medicine, Jeonbuk National University Medical School and Research Institute of Clinical Medicine of Jeonbuk National University-Biomedical Research Institute of Jeonbuk National University Hospital, Jeonju, Korea

³Department of Cardiology in Internal Medicine, Chungnam National University Sejong Hospital, Sejong, Korea

⁴Division of Statistics, Office of Information Security, Korea Institute of Toxicology, Daejeon, Korea

This corrects the article "Comparative efficacy and safety of warfarin and direct oral anticoagulants in patients with end-stage kidney disease and atrial fibrillation" in Volume 41 on page 107.

Korean J Intern Med 2026;41:107–117

https://doi.org/10.3904/kjim.2025.052

The graphical abstract has been revised to more accurately represent the study population and to improve the clarity and consistency of the presentation of the study methods and findings. The original graphical abstract will be replaced with the revised version shown below.

Article information Continued

(open-access) :

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.